GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 55 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $9,000 | +80.0% | 16,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $5,000 | -72.2% | 16,000 | -30.7% | 0.00% | -66.7% |
Q3 2018 | $18,000 | -81.4% | 23,100 | -79.6% | 0.00% | -76.9% |
Q2 2018 | $97,000 | -18.5% | 113,100 | 0.0% | 0.01% | -13.3% |
Q1 2018 | $119,000 | -9.2% | 113,100 | 0.0% | 0.02% | -28.6% |
Q4 2017 | $131,000 | -27.2% | 113,100 | -8.1% | 0.02% | -25.0% |
Q3 2017 | $180,000 | – | 123,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 25,000,000 | $21,250,000 | 1.00% |
Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $1,685,000 | 0.92% |
Vivo Capital, LLC | 8,180,000 | $7,000,000 | 0.90% |
Ghost Tree Capital, LLC | 3,525,000 | $3,016,000 | 0.89% |
BVF INC/IL | 5,265,000 | $4,505,000 | 0.44% |
Birchview Capital, LP | 189,000 | $162,000 | 0.11% |
Quinn Opportunity Partners LLC | 113,100 | $97,000 | 0.01% |
Centiva Capital, LP | 72,234 | $62,000 | 0.01% |
DRW Securities, LLC | 240,000 | $205,000 | 0.01% |
Alyeska Investment Group, L.P. | 1,603,085 | $1,372,000 | 0.01% |